Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Connective tissue growth factor (CTGF) is a multifunctional cellular protein and playing a role as a central mediator in tissue remodeling and fibrosis. The physiological function of CTGF in psoriasis is unknown. Objective: The purpose of this study was to investigate the function of CTGF in psoriasis using the established imiquimod (IMQ)- induced psoriasis murine model and psoriasis patients. Methods: Anti-CTGF monoclonal antibody was applied to IMQ induced psoriasis mice and those skin were clinically, pathologically and immunologically analyzed. Additionally, CTGF expression was analyzes using skin samples and plasma from psoriasis patients. Results: CTGF expression was observed in the dermis from both IMQ-induced psoriatic mice and psoriasis patients. CTGF inhibition using an anti-CTGF antibody slightly worsened IMQ-induced dermatitis. In addition, the increase of CTGF showed tendency to suppress the psoriatic dermatitis through inhibition of suprabasal cells proliferation and macrophage infiltration in the skin. CTGF was also detected significantly higher in plasma from psoriasis patients comparing with healthy control. Conclusion: Our findings suggest that CTGF could contribute to the healing rather than the worsening of psoriasis skin lesions.
Abstract
Background: Connective tissue growth factor (CTGF) is a multifunctional cellular protein and playing a role as a central mediator in tissue remodeling and fibrosis. The physiological function of CTGF in psoriasis is unknown. Objective: The purpose of this study was to investigate the function of CTGF in psoriasis using the established imiquimod (IMQ)- induced psoriasis murine model and psoriasis patients. Methods: Anti-CTGF monoclonal antibody was applied to IMQ induced psoriasis mice and those skin were clinically, pathologically and immunologically analyzed. Additionally, CTGF expression was analyzes using skin samples and plasma from psoriasis patients. Results: CTGF expression was observed in the dermis from both IMQ-induced psoriatic mice and psoriasis patients. CTGF inhibition using an anti-CTGF antibody slightly worsened IMQ-induced dermatitis. In addition, the increase of CTGF showed tendency to suppress the psoriatic dermatitis through inhibition of suprabasal cells proliferation and macrophage infiltration in the skin. CTGF was also detected significantly higher in plasma from psoriasis patients comparing with healthy control. Conclusion: Our findings suggest that CTGF could contribute to the healing rather than the worsening of psoriasis skin lesions.
참고문헌 (18)
- Leask A, "Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma", J Invest Dermatol, 122, pp.1~6 (2004)[DOI]
- Igarashi A, "Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis", J Invest Dermatol, 105, pp.280~284 (1995)[DOI]
- Takigawa M, "Role of CTGF", HCS24, J Cell Physiol, pp.2003, 194[DOI]
- Nozawa K, "Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis", Arthritis Res Ther, 11, pp.R174~ (2009)[DOI]
- Nozawa K, "Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis", Arthritis Rheum, 65, pp.1477~1486 (2013)[DOI]
- Lowes MA, "Immunology of psoriasis", Annu Rev Immunol, 32, pp.227~255 (2014)[DOI]
- Reich K, "Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial", Lancet, 366, pp.1367~1374 (2005)[DOI]
- Coates LC, "Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same?", Semin Arthritis Rheum, 46, pp.291~304 (2016)[DOI]
- van der Fits L, "Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23", IL-17 axis, 2009, pp.182, 5836~5845
- Miyazaki O, "Subtraction method for determination of N-terminal connective tissue growth factor", Ann Clin Biochem, 47, pp.205~211 (2010)[DOI]
- Fujishiro M, "The detection of plasma levels of connective tissue growth factor in rheumatoid arthritis patients", Clin Exp Rheumatol, 30, pp.145~146 (2012)
- Swindell WR, "Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis", PLoS One, 6, pp.e18266~ (2011)[DOI]
- DiPietro LA, "Wound healing: the role of the macrophage and other immune cells", Shock, 4, pp.233~240 (1995)[DOI]
- Waugh HV, "Macrophage dynamics in diabetic wound dealing", Bull Math Biol, 68, pp.197~207 (2006)[DOI]
- Alfaro MP, "A physiological role for connective tissue growth factor in early wound healing", Lab Invest, 93, pp.81~95 (2013)
- Henshaw FR, "Topically applied connective tissue growth factor", CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing, 2015, pp.2015, 236238~
- Riley KG, "Macrophages are essential for CTGFmediated adult <TEX>${\beta}$<", TEX>-cell proliferation after injury, 2015, pp.4, 584~591
- Cicha I, "Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro", Arterioscler Thromb Vasc Biol, 25, pp.1008~1013 (2005)[DOI]